
Full text loading...
Flora Tang started biotech consulting on drug discovery operation and technology in 2007. Flora has extensive pharmaceutical experiences working at Amgen as Director of Research; SUGEN (subsidiary of Pharmacia) as Director of Discovery Technology; Eli Lilly; and GlaxoSmithKline. The scope of her work experiences involves high throughput biology using cutting-edge technologies and managing business operations. Flora started applying high content screening to drug discovery process soon after the inception of HCS.